pirinixic acid has been researched along with interleukin-8 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernd, A; Dang, TA; Grundmann-Kollmann, M; Hardt-Weinelt, K; Kaufmann, R; Kippenberger, S; Loitsch, SM; Simon, S | 1 |
| Danziger, EC; Hatley, ME; Hedrick, CC; Reilly, KB; Srinivasan, S | 1 |
| Corbett, L; Knox, AJ; Nie, M; Pang, L | 1 |
| Choi, KY; Kim, B; Kim, H; Kim, JE; Lee, JD; Lee, SH | 1 |
| Ayers, SD; Bernardes, A; Godoy, AS; Muniz, JR; Parekh, NM; Polikarpov, I; Reinach, P; Ricci, CG; Skaf, MS; Souza, PC; Trivella, DB; Webb, P | 1 |
5 other study(ies) available for pirinixic acid and interleukin-8
| Article | Year |
|---|---|
Activators of peroxisome proliferator-activated receptors protect human skin from ultraviolet-B-light-induced inflammation.
Topics: Cell Division; Cell Line, Transformed; Dermatitis; DNA Primers; Down-Regulation; Erythema; Gene Expression; Humans; Interleukin-6; Interleukin-8; Keratinocytes; Peroxisome Proliferators; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Response Elements; Skin; Transcription Factors; Ultraviolet Rays | 2001 |
Modulation of PPARalpha expression and inflammatory interleukin-6 production by chronic glucose increases monocyte/endothelial adhesion.
Topics: Animals; Aorta; Cell Adhesion; Diabetes Mellitus, Type 2; Endothelial Cells; Endothelium, Vascular; Glucose; Humans; Interleukin-6; Interleukin-8; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Mutant Strains; Monocytes; Pioglitazone; Pyrimidines; Receptors, Cytoplasmic and Nuclear; Recombinant Proteins; Thiazolidinediones; Transcription Factors | 2004 |
Differential regulation of chemokine expression by peroxisome proliferator-activated receptor gamma agonists: interactions with glucocorticoids and beta2-agonists.
Topics: Adrenergic beta-Agonists; Albuterol; Androstadienes; Blotting, Western; Cell Line; Chemokine CCL11; Chemokine CCL2; Chemokines; Chemokines, CC; Chromans; Chromatin; Chromatin Immunoprecipitation; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Fluticasone; Gene Expression Regulation; Glucocorticoids; Humans; Immunoprecipitation; Interleukin-8; Plasmids; PPAR alpha; PPAR gamma; Promoter Regions, Genetic; Prostaglandin D2; Protein Binding; Pyrimidines; Receptors, Glucocorticoid; Reverse Transcriptase Polymerase Chain Reaction; RNA; Salmeterol Xinafoate; Thiazolidinediones; Transcription, Genetic; Transfection; Troglitazone; Tumor Necrosis Factor-alpha | 2005 |
Co-treatment with retinyl retinoate and a PPARα agonist reduces retinoid dermatitis.
Topics: Administration, Topical; Animals; Cell Differentiation; Cell Proliferation; Dermatitis; Enzyme Inhibitors; Epidermis; Female; Interleukin-1alpha; Interleukin-8; Keratolytic Agents; Liver X Receptors; Mice; Mice, Hairless; Orphan Nuclear Receptors; Palmitic Acid; PPAR alpha; Pyrimidines; Retinoids; Retinyl Esters; RNA, Messenger; Tretinoin; Tumor Necrosis Factor-alpha; Water Loss, Insensible | 2012 |
Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization.
Topics: Anti-Inflammatory Agents; Cells, Cultured; Crystallography, X-Ray; Dose-Response Relationship, Drug; Humans; Interleukin-6; Interleukin-8; Kinetics; Models, Molecular; Molecular Dynamics Simulation; PPAR alpha; Protein Conformation; Pyrimidines | 2013 |